AorTech blames Ultracor for disappointing results:
This article was originally published in Clinica
AorTech International, a UK company which produces the Ultracor mechanical heart valve, says that a downturn in its annual sales, from last year's £2.2 million ($3.6 million) to this year's £1.8 million was due primarily to disappointing sales of the valves. However, losses also diminished. The company is predicting that the results of a major study in Germany on the valve's performance should have a "significant positive impact on sales during ensuing years". AorTech raised $3 million in May through a share issue to new and existing shareholders (see Clinica No 809, p 11).